Medicare Enrolled

Dr. Ravi Rajan, M.D.

Urology Physician · Lawrenceville, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3311 BRUNSWICK PIKE, Lawrenceville, NJ 08648
6097167030
In practice since 2006 (20 years)
NPI: 1831135078 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rajan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rajan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rajan

Dr. Ravi Rajan is an urology physician in Lawrenceville, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rajan performed 5,854 Medicare services across 3,219 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rajan received a total of $67,013 from 48 pharmaceutical and/or device companies across 399 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rajan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 23% volume in NJ $67,013 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,854
Medicare services
Top 23% in NJ for urology physician
3,219
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~293 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,702 $96 $274
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
1,425 $2 $10
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
1,317 $8 $115
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
345 $65 $179
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
138 $66 $188
Leuprolide acetate (for depot suspension), 7.5 mg 132 $137 $413
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
111 $120 $412
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
101 $143 $497
Bladder and urethra clot removal with endoscope
A procedure using an endoscope to irrigate and remove multiple blood clots from the bladder and urethra.
79 $365 $2,089
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
78 $201 $890
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
64 $109 $336
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
49 $27 $121
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
45 $89 $371
Imaging of urinary tract with contrast
An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures.
39 $20 $70
Shock wave crushing of kidney stones
A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body.
30 $475 $5,085
Limited retroperitoneal ultrasound
A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures.
29 $37 $201
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
26 $360 $2,290
Endoscopic removal of urethral or bladder foreign body
A procedure to remove a stone, stent, or other object from the urethra or bladder using an endoscope. The endoscope allows the provider to visualize and extract the item through the urinary tract.
23 $398 $2,095
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
22 $90 $2,500
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $47 $116
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
20 $201 $1,443
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
16 $52 $425
Endoscopic destruction of bladder/urethra growth, less than 0.5 cm
A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters.
15 $670 $3,558
Complete pelvic ultrasound
An imaging test using sound waves to create pictures of the organs and structures within the pelvis.
15 $76 $389
Waterjet prostate destruction via urethra
A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra.
12 $586 $11,200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
27.0% medium
72.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$67,013
Total received (2018-2024)
Avg $9,573/year across 7 years
Top 4% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
399
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$59,499 (88.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,920 (8.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,595 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,524
2023
$7,699
2022
$4,548
2021
$5,510
2020
$14,542
2019
$19,610
2018
$4,580

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$7,304
PFIZER INC.
$2,250
Myriad Genetic Laboratories, Inc.
$480
BLUEWIND MEDICAL
$154
Sumitomo Pharma America, Inc.
$134
PROCEPT BioRobotics Corporation
$89
Teleflex LLC
$85
Medtronic, Inc.
$14
Boston Scientific Corporation
$14
Top 3 companies account for 95.3% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$32,012
PFIZER INC.
$24,784
Pfizer Inc.
$1,900
Aytu BioScience, Inc
$1,551
Myriad Genetic Laboratories, Inc.
$1,197
NeoTract Inc.
$523
Bard Peripheral Vascular, Inc.
$400
Janssen Biotech, Inc.
$383
Medtronic USA, Inc.
$344
Antares Pharma, Inc.
$331
PROCEPT BioRobotics Corporation
$304
Teleflex LLC
$280
Kowa Pharmaceuticals America, Inc.
$274
Medtronic, Inc.
$265
Dendreon Pharmaceuticals LLC
$223
Sumitomo Pharma America, Inc.
$203
Bayer HealthCare Pharmaceuticals Inc.
$173
BLUEWIND MEDICAL
$154
TOLMAR Pharmaceuticals, Inc.
$144
Ferring Pharmaceuticals Inc.
$126
Myovant Sciences Inc.
$115
COMSORT, Inc
$100
AbbVie Inc.
$98
AbbVie, Inc.
$95
Blue Earth Diagnostics Limited
$91
Amgen Inc.
$87
UROVANT SCIENCES INC
$78
Mission Pharmacal Company
$77
Boston Scientific Corporation
$77
Janssen Products, LP
$65
Merck Sharp & Dohme Corporation
$61
BOSTON SCIENTIFIC CORPORATION
$48
Allergan, Inc.
$47
Avadel Specialty Pharmaceuticals, LLC
$44
Endo Pharmaceuticals Inc.
$41
180 Medical, Inc.
$40
Allergan Inc.
$38
COLOPLAST CORP
$34
Clarus Therapeutics Inc.
$30
Coloplast Corp
$27
Acerus Pharmaceuticals Corporation
$25
Alnylam Pharmaceuticals Inc.
$23
NxThera, Inc.
$20
C. R. BARD, INC. & SUBSIDIARIES
$19
SRS Medical Systems, Inc.
$18
Sun Pharmaceutical Industries Inc.
$17
ROCHESTER MEDICAL CORPORATION
$16
Axonics Modulation Technologies, Inc.
$11
Top 3 companies account for 87.6% of all-time payments
Associated products mentioned in payments ›
AMS · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · Amplatz Super Stiff · Androgel · AquaBeam Robotic System · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENTLECATH · INTERSTIM · JATENZO · KEYTRUDA · LUPRON DEPOT · Livalo · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ODOMZO · ORGOVYX · OTREXUP · OXLUMO · Otrexup · PROLARIS · PROVENGE · Prolaris · Prolia · REVI · REZUM · Rezum · SEGLENTIS · SPEEDICATH · Seglentis · Spanner Prothetic Stent · SpeediCath · TOVIAZ · Titan · Tria Firm · UROLIFT · Uribel · UroLift · UroLift System · Urolift · VESICARE · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for urology physician in NJ.

Looking for an urology physician in Lawrenceville?
Compare urology physicians in the Lawrenceville area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
145
Per 100K population
37.8
County median income
$96,333
Nearest hospital
CAPITAL HEALTH REGIONAL MEDICAL CENTER
3.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rajan is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NJ), with speaking/promotional industry engagement in the top 4% of NJ peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rajan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rajan performed 1,702 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rajan receive payments from pharmaceutical companies?
Yes. Dr. Rajan received a total of $67,013 from 48 companies across 399 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rajan's costs compare to other urology physicians in Lawrenceville?
Dr. Rajan's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rajan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →